Facebook Pixel

Study: Earlier Hormone Therapy Elevates Breast Cancer Risk

By Expert HERWriter Guide Blogger
Rate This
Breast Cancer related image Photo: Getty Images

A major study has found that women with the greatest risk of breast cancer are those who started hormone therapy the earliest - before or soon after menopause started. The finding means that women thought to be at lower risk for breast cancer from hormone therapy may actually be at the highest risk.

The finding comes from the Million Women Study (MWS)—a large observational study in the United Kingdom—and adds to a growing body of evidence that the use of combined hormone therapy (estrogen plus progestin) to treat menopausal symptoms increases the risk of breast cancer and deaths from the disease.

The study included more than a million postmenopausal women, one in four British women who were aged 50 to 64 during the enrollment period, from May 1996 to December 2001.The results appeared in the Journal of the National Cancer Institute on January 28, 2011.

The pattern of increased breast cancer risk “was seen across different types of hormonal therapy, among women [in the MWS] who used hormonal therapy for either short or long durations, and also in lean and in overweight and obese women,” wrote Dr. Valerie Beral of Oxford University and her colleagues. The findings support results from the Women’s Health Initiative (WHI), a randomized clinical trial that, in 2002, first reported evidence linking combined hormone use to breast cancer.

“The new findings underscore the idea that there’s really no safe window of time for women to take combined hormone therapy,” said Dr. Leslie Ford of the National Cancer Institute's Division of Cancer Prevention and the Institute’s WHI liaison. After the initial WHI results were announced, she noted, some people had argued that hormones may be safer when started at the time of menopause. “The new findings refute that argument,” she added.

WHI and MWS investigators have both reported that breast cancer incidence rates declined rapidly once women stopped taking combined hormone therapy. “It is important for women to know that if they stop using hormones, the risk of breast cancer very quickly returns to where it was before hormone therapy began,” Ford said.


Add a Comment1 Comments

Most of the women in the Million Women Study used estrogen-progestin hormone formulations which are not naturally found in women's bodies, i.e., they are not bioidentical hormones. Progestins have been implicated in multiple studies as the components which are probably responsible for the increased risk of breast cancer, although CEE (oral equine estrogens) have also been implicated.

For more info see my blog on estrogens and breast cancer:

February 17, 2011 - 5:07pm
Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy
Add a Comment
Expert HERWriter Guide Blogger View Profile Send Message

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

Breast Cancer

Get Email Updates

Related Checklists

Breast Cancer Guide


Have a question? We're here to help. Ask the Community.


Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!